The Shalby IPO date has been confirmed to have started on December 5, 2017 and ended on December 7, 2017.
Using an IPO, Shalby is seeking to raise Rs 504.80 crores. Its price band is set at ₹245 to ₹248 per share. The minimum lot size for an application is 60 Shares. The minimum amount of investment required by retail investors is ₹14,880.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Dec 5-7
Price Range
₹245 to ₹248 per share
Face Value
₹10 per share
GMP
₹315.00
Shalby IPO GMP
The Shalby Limited IPO GMP is ₹315.00.
IPO Overview
The Shalby Hospital IPO is a Rs 504.80 crore book-built issue. The offering consists of a fresh issue of Rs 480.00 crore and an offer to sell 0.1 crore shares. Bidding for the Shalby Hospital IPO began on December 5, 2017 and finished on December 7, 2017. The Shalby Hospital IPO allotment was completed on Tuesday, December 12, 2017. On December 15, 2017, the shares were listed on the BSE and NSE. The pricing range for Shalby Hospital’s initial public offering is $245 to $248 per share. An application requires a minimum lot size of 60 Shares. Retail investors must make a minimum investment of $14,880.
Dr. Vikram Shah, an orthopaedic surgeon with over 25 years of expertise, leads Shalby Hospital. Dr. Vikram Shah is one of the company’s promoters. As of December 31, 2016, Shalby Hospital employed 1,599 people and had 267 professional consultants, including 242 full-time consultants and 25 part-time consultants. The hospital also employs 458 nurses, 1,141 paramedics, corporate and support personnel, and chemists.
Shalby IPO Details
| IPO Date | December 5, 2017 to December 7, 2017 |
| Listing Date | December 15, 2017 |
| Face Value | ₹10 per share |
| Price Band | ₹245 to ₹248 per share |
| Lot Size | 60 Shares |
| Total Issue Size | [.] shares (aggregating up to ₹504.80 Cr) |
| Fresh Issue | [.] shares (aggregating up to ₹480.00 Cr) |
| Offer for Sale | 1,000,000 shares of ₹10 (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Shalby Company Financials
| Particulars | For the year/period ended (in Rs. million) | |||||
|---|---|---|---|---|---|---|
| 31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
| Total Assets | 7181.75 | 5,039.14 | 3,513.41 | 2,168.30 | 1,520.96 | |
| Total Revenue | 3,328.62 | 2,925.56 | 2,776.26 | 2,616.76 | 2,298.28 | |
| Profit After Tax | 615.74 | 363.19 | 245.52 | 377.47 | 150.09 | |
Shalby IPO Timeline.
| IPO Open Date | Tuesday, December 5, 2017 |
| IPO Close Date | Thursday, December 7, 2017 |
| Basis of Allotment | Tuesday, December 12, 2017 |
| Initiation of Refunds | Wednesday, December 13, 2017 |
| Credit of Shares to Demat | Thursday, December 14, 2017 |
| Listing Date | Friday, December 15, 2017 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 7, 2017 |
Company Profile
Shalby Limited, headquartered in Ahmedabad, Gujarat, is one of India’s biggest multi-specialty hospital chains. The company provides inpatient and outpatient healthcare services through 8 fully operational hospitals, totaling 781 operational beds. In addition, the company offers outpatient consultation healthcare services through three hospitals and 68 outpatient clinics. The company operates eight shared surgery centres in third-party hospitals. Orthopaedic services are well-known in Shalby hospitals. In 2016, Shalby Hospital accounted for 15% of all joint
replacement procedures performed by private corporate hospitals in India. Aside from orthopaedics, Shalby hospitals offer sophisticated care in a variety of specialties, including neurology, cardiac care, critical care, oncology, and nephrology. Since March 2007, Shalby hospitals have performed 84,579 surgeries and served 923,441 patients, including 121,576 inpatients and 801,865 outpatients. Shalby hospitals are located in five states, while Outpatient Clinics are located in 53 cities throughout 16 states. The company also has six outpatient clinics and one Shalby Arthroplasty Centre of Excellence (SACE) across Africa, as well as two SACE in the UAE.
Registrar Info
| Name | Kfin Technologies Limited |
| Phone number | 04067162222, 04079611000 |
| Email ID | einward.ris@karvy.com |
| Website | kosmic.kfintech.com |
Contact Details
| Name | Shalby Limited |
| Phone number | +91 79 4020 3000 |
| Email ID | companysecretary@shalby.in |
| Website | shalby.org |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
